cocaine and ritanserin

cocaine has been researched along with ritanserin in 21 studies

Research

Studies (21)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	13 (61.90)	18.2507
2000's	7 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (4.76)	2.80

Authors

Authors	Studies
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Battaglia, G; Cabrera, TM; Kerr, JE; Levy, AD; Li, Q; Rittenhouse, PA; Van de Kar, LD	1
Ashton, D; Clincke, GH; Dugovic, C; Meert, TF	1
Clincke, G; Meert, T	1
Awouters, F; Janssen, PA; Meert, TF; Niemegeers, CJ; Schellekens, KH	1
Janssen, PA	1
Emmett-Oglesby, MW; Peltier, RL; Schenk, S; Thomas, WH	1
Björk, A; Hill, LJ; Jones, EA; McMillen, BA; Myers, RD; Williams, HL	1
Childress, AR; Cornish, JW; Ehrman, RN; O'Brien, CP; Robbins, SJ	2
Chen, YR; Clyde, C; Johnson, BA; Johnson, P; Lesser, J; Ruiz, P; Schmitz, J; Swann, AC	1
Schrott, LM; Sparber, SB; Zhang, X	1
Furukawa, H; Kamei, H; Mamiya, T; Miyamoto, Y; Nabeshima, T; Noda, Y	1
Getty, ME; Schrott, LM; Sparber, SB; Wacnik, PW	1
Heron-Maxwell, CL; O'Neill, MF; Shaw, G	1
Schenk, S	1
Gessa, GL; Marchese, G; Pani, L; Ruiu, S; Saba, PL	1
Schrott, LM; Sparber, SB	1
Ago, Y; Baba, A; Hayashi, A; Itoh, S; Matsuda, T; Nakamura, S	1
Ago, Y; Baba, A; Matsuda, T; Nakamura, S	1
Makiguchi, A; Okada, T; Shioda, K; Suda, S	1

Reviews

2 review(s) available for cocaine and ritanserin

Article

Year

Addiction and the potential for therapeutic drug development.

EXS, 1994, Volume: 71

Topics: Alcoholism; Animals; Cocaine; Disease Models, Animal; Double-Blind Method; Humans; Research Design; Ritanserin; Substance-Related Disorders

1994

Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.

Journal of pharmacological sciences, 2008, Volume: 106, Issue:1

Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Bridged Bicyclo Compounds, Heterocyclic; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Dioxanes; Dioxoles; Disease Models, Animal; Ligands; Methamphetamine; Mice; Motor Activity; Oxazines; Receptors, Serotonin; Ritanserin; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists

2008

Trials

3 trial(s) available for cocaine and ritanserin

Article	Year
Addiction and the potential for therapeutic drug development. EXS, 1994, Volume: 71 Topics: Alcoholism; Animals; Cocaine; Disease Models, Animal; Double-Blind Method; Humans; Research Design; Ritanserin; Substance-Related Disorders	1994
Failure of ritanserin to block cocaine cue reactivity in humans. Drug and alcohol dependence, 1996, Volume: 42, Issue:3 Topics: Arousal; Cocaine; Cues; Galvanic Skin Response; Heart Rate; Humans; Motivation; Neurologic Examination; Opioid-Related Disorders; Ritanserin; Serotonin Antagonists; Single-Blind Method; Skin Temperature; Treatment Outcome	1996
Ritanserin in the treatment of cocaine dependence. Biological psychiatry, 1997, Nov-15, Volume: 42, Issue:10 Topics: Adult; Cocaine; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Ritanserin; Serotonin Antagonists; Severity of Illness Index; Substance-Related Disorders	1997

Other Studies

17 other study(ies) available for cocaine and ritanserin

Article	Year
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
Cocaine-induced suppression of renin secretion is partially mediated by serotonergic mechanisms. Pharmacology, biochemistry, and behavior, 1992, Volume: 42, Issue:3 Topics: 5,7-Dihydroxytryptamine; Animals; Cocaine; Injections, Intraventricular; Male; Neurons; Piperazines; Rats; Rats, Sprague-Dawley; Renin; Ritanserin; Serotonin; Yohimbine	1992
Effects of ritanserin and chlordiazepoxide on sleep-wakefulness alterations in rats following chronic cocaine treatment. Psychopharmacology, 1992, Volume: 108, Issue:3 Topics: Animals; Chlordiazepoxide; Cocaine; Male; Rats; Rats, Inbred Strains; Ritanserin; Sleep; Sleep, REM; Substance Withdrawal Syndrome; Wakefulness	1992
Evidence for a possible role of the 5-HT2 antagonist ritanserin in drug abuse. Annals of the New York Academy of Sciences, 1992, Jun-28, Volume: 654 Topics: Alcoholic Intoxication; Animals; Cocaine; Fentanyl; Lysergic Acid Diethylamide; Motor Activity; Rats; Receptors, Serotonin; Ritanserin; Substance-Related Disorders	1992
Ritanserin reduces abuse of alcohol, cocaine, and fentanyl in rats. Pharmacopsychiatry, 1991, Volume: 24, Issue:5 Topics: Animals; Cocaine; Drinking; Ethanol; Fentanyl; Male; Rats; Rats, Inbred Strains; Ritanserin; Substance-Related Disorders	1991
Failure of ritanserin to block the discriminative or reinforcing stimulus effects of cocaine. Pharmacology, biochemistry, and behavior, 1994, Volume: 48, Issue:2 Topics: Animals; Cocaine; Conditioning, Operant; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Motor Activity; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Reinforcement Schedule; Reinforcement, Psychology; Ritanserin; Self Administration	1994
Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats. Pharmacology, biochemistry, and behavior, 1993, Volume: 46, Issue:1 Topics: Animals; Behavior, Animal; Brain Chemistry; Cocaine; Drinking Behavior; Feeding Behavior; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Ritanserin; Self Administration; Serotonin Antagonists	1993
Evidence for a serotonin-mediated effect of cocaine causing vasoconstriction and herniated umbilici in chicken embryos. Pharmacology, biochemistry, and behavior, 1998, Volume: 59, Issue:3 Topics: Amphetamines; Animals; Chick Embryo; Cocaine; Dose-Response Relationship, Drug; Hernia, Umbilical; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Vasoconstriction; Vasoconstrictor Agents	1998
Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:1 Topics: alpha-Methyltyrosine; Animals; Benzazepines; Cocaine; Conditioning, Psychological; Male; Mice; Oxidopamine; Phencyclidine; Receptors, Dopamine D1; Receptors, Serotonin; Ritanserin	1998
Open-field and LPS-induced sickness behavior in young chickens: effects of embryonic cocaine and/or ritanserin. Pharmacology, biochemistry, and behavior, 1998, Volume: 61, Issue:1 Topics: Animals; Behavior, Animal; Chick Embryo; Chickens; Cocaine; Dopamine Uptake Inhibitors; Drug Interactions; Environment; Female; Lipopolysaccharides; Male; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Ritanserin; Serotonin Antagonists; Sex Characteristics	1998
5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB. Pharmacology, biochemistry, and behavior, 1999, Volume: 63, Issue:2 Topics: Aminopyridines; Amphetamine; Animals; Benzazepines; Cocaine; Dizocilpine Maleate; Dopamine Agonists; Drug Interactions; Female; Fluorobenzenes; Indoles; Mice; Motor Activity; Piperidines; Ritanserin; Serotonin Antagonists	1999
Mood state and recent cocaine use are not associated with levels of cocaine cue reactivity. Drug and alcohol dependence, 2000, Apr-01, Volume: 59, Issue:1 Topics: Adult; Affect; Arousal; Cocaine; Cocaine-Related Disorders; Crack Cocaine; Cues; Drug Administration Schedule; Galvanic Skin Response; Humans; Male; Middle Aged; Motivation; Ritanserin	2000
Effects of the serotonin 5-HT(2) antagonist, ritanserin, and the serotonin 5-HT(1A) antagonist, WAY 100635, on cocaine-seeking in rats. Pharmacology, biochemistry, and behavior, 2000, Volume: 67, Issue:2 Topics: Animals; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Male; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Ritanserin; Saccharin; Self Administration; Serotonin Antagonists	2000
The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex. Molecular psychiatry, 2000, Volume: 5, Issue:6 Topics: Animals; Clozapine; Cocaine; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Frontal Lobe; Haloperidol; Ketanserin; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Risperidone; Ritanserin; Serotonin Antagonists; Synaptosomes; Tritium	2000
Embryonic "binge" cocaine exposure alters neural-immune and neural-endocrine interactions in young chickens: involvement of serotonin(2) receptors. Brain research. Developmental brain research, 2001, Sep-23, Volume: 130, Issue:1 Topics: Animals; Basophils; Chick Embryo; Chickens; Cocaine; Corticosterone; Dopamine Uptake Inhibitors; Fever; Hypersensitivity, Delayed; Lipopolysaccharides; Neuroimmunomodulation; Phytohemagglutinins; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Social Isolation; Stress, Psychological	2001
Effects of osemozotan, ritanserin and azasetron on cocaine-induced behavioral sensitization in mice. Pharmacology, biochemistry, and behavior, 2006, Volume: 85, Issue:1 Topics: Animals; Antipsychotic Agents; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Cocaine; Dioxanes; Dioxoles; Male; Mice; Oxazines; Ritanserin	2006
Risperidone and 5-HT2A Receptor Antagonists Attenuate and Reverse Cocaine-Induced Hyperthermia in Rats. The international journal of neuropsychopharmacology, 2020, 12-29, Volume: 23, Issue:12 Topics: Animals; Benzazepines; Cocaine; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Hyperthermia; Ketanserin; Male; Rats; Rats, Wistar; Risperidone; Ritanserin; Serotonin 5-HT2 Receptor Antagonists	2020